We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Immunomedics Inc in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 403 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 408 → 0 (-408)

100% less funds holding in top 10

Funds holding in top 10: 68 → 0 (-68)

100% less capital invested

Capital invested by funds: $17B → $0 (-$17B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 403

Holders
–
Holders Change
-408
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-68
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
403
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$2.23B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.54B
3
BlackRock
BlackRock
New York
-$1.14B
4
HI
HBK Investments
Texas
-$553M
5
FCM
Farallon Capital Management
California
-$498M
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
101
Point72 Asset Management
Connecticut
– -$25.5M -300,000 Closed
Loomis, Sayles & Company
102
Loomis, Sayles & Company
Massachusetts
– -$25.2M -296,702 Closed
VanEck Associates
103
VanEck Associates
New York
– -$25.2M -296,489 Closed
UBS Group
104
UBS Group
Switzerland
– -$24.8M -291,642 Closed
SCS
105
Syquant Capital SAS
France
– -$22.8M -267,925 Closed
Verition Fund Management
106
Verition Fund Management
Connecticut
– -$22.8M -267,697 Closed
Dimensional Fund Advisors
107
Dimensional Fund Advisors
Texas
– -$22.5M -264,808 Closed
DCM
108
DAFNA Capital Management
California
– -$22.2M -260,905 Closed
GCIA
109
Gabelli & Co Investment Advisers
New York
– -$21.9M -257,000 Closed
State Board of Administration of Florida Retirement System
110
State Board of Administration of Florida Retirement System
Florida
– -$21.8M -256,808 Closed
Ensign Peak Advisors
111
Ensign Peak Advisors
Utah
– -$21.8M -256,753 Closed
HF
112
HRT Financial
New York
– -$21.8M -256,195 Closed
PPA
113
Parametric Portfolio Associates
Washington
– -$21.1M -248,322 Closed
E
114
Ergoteles
New York
– -$21.1M -248,006 Closed
NIP
115
Nicholas Investment Partners
California
– -$20.9M -245,698 Closed
BHMP
116
Bardin Hill Management Partners
New York
– -$20.7M -243,653 Closed
RhumbLine Advisers
117
RhumbLine Advisers
Massachusetts
– -$20.4M -239,936 Closed
BBA
118
Baker Bros. Advisors
New York
– -$20.2M -237,694 Closed
AII
119
AGF Investments Inc
Ontario, Canada
– -$19.6M -230,445 Closed
TCM
120
Tekla Capital Management
Massachusetts
– -$19M -223,336 Closed
RPAM
121
Rhenman & Partners Asset Management
Sweden
– -$18.8M -221,351 Closed
Royal Bank of Canada
122
Royal Bank of Canada
Ontario, Canada
– -$18.8M -220,582 Closed
SAM
123
Stansberry Asset Management
Texas
– -$18.5M -217,120 Closed
FTCM
124
First Trust Capital Management
Illinois
– -$17.8M -209,046 Closed
AC
125
Athanor Capital
New York
– -$17.6M -207,037 Closed
3 4
5
6 7

IMMU Hedge Fund Activity: Q4 2020 in Review

0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2020, worth a combined $0 — down 100% from $17B a quarter earlier.

Sellers outnumbered buyers: 403 funds closed out of IMMU and 0 opened new positions — a net loss of 403 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $2.23B sold.

  • 0 institutional investors held Immunomedics Inc (IMMU) as of Q4 2020, down from 408 in Q3 2020.
  • Funds reported $0 of Immunomedics Inc stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Immunomedics Inc positions in Q4 2020 and 403 closed out, a net change of -403 holders.
  • The largest Immunomedics Inc seller in Q4 2020 was Avoro Capital Advisors, an estimated $2.23B sold.

Based on aggregated 13F filings for Q4 2020.